Current Molecular Pharmacology

Editor-in-Chief:

Michael Kahn
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000
USA

Back

GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting

Volume:5   Issue:3
Pp: 317-326
Alicia N. Harvey, Kristy Nguyen and Anastasios Lymperopoulos
DOI: 10.2174/1874467211205030001

Crosstalk Signalling Role in Modulation of Drugs Side Effects

Volume:5   Issue:3
Pp: 327-339
Susanna P. Garamszegi and Nandor Garamszegi
DOI: 10.2174/1874467211205030002

Parkinson's Disease: A Role for the Immune System

Volume:5   Issue:3
Pp: 340-349
Dwight C. German, Todd Eagar and Patricia K. Sonsalla
DOI: 10.2174/1874467211205030003

G-Protein Coupled Receptor Resensitization - Appreciating the Balancing Act of Receptor Function

Volume:5   Issue:3
Pp: 350-361
Maradumane L. Mohan, Neelakantan T. Vasudevan, Manveen K. Gupta, Elizabeth E. Martelli and Sathyamangla V. Naga Prasad
DOI: 10.2174/1874467211205030004

microRNA, Cancer and Cancer Chemoprevention

Volume:5   Issue:3
Pp: 362-371
Xun Che and Chuanshu Huang
DOI: 10.2174/1874467211205030005

Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled

Volume:5   Issue:3
Pp: 382-391
Irina Veytsman, Jeanny B. Aragon-Ching and Sandra M. Swain
DOI: 10.2174/1874467211205030007

Estrogen Receptor Expression and its Relevant Signaling Pathway in Prostate Cancer: A Target of Therapy

Volume:5   Issue:3
Pp: 392-400
Yasuhiro Nakamura, Keely M McNamara and Hironobu Sasano
DOI: 10.2174/1874467211205030008

Acknowledgement To Reviewers

Volume:5   Issue:3
Pp: 401-401

DOI: 10.2174/1874467211205030009